文献速递心外重症与机械循环支持

需要静脉-静脉体外支持患者的体重指数与死亡率关系并非线性

The relationship between body mass index and mortality is not linear in patients requiring venovenous extracorporeal support.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-11-30

结果显示高龄和Charlson合并症指数较高与死亡率增加相关,BMI与死亡率呈非线性关系,BMI 32至37之间者调整后死亡率低于BMI 25至32之间者。

要点

  • 高龄(P<.0001)和Charlson合并症指数较高(P=.009)分别与死亡率增加相关。
  • BMI与死亡率存在非线性关系,BMI 32至37之间者调整后死亡率低于BMI 25至32之间者。
  • BMI 40至60与BMI第25、50、75百分位相比,ECMO死亡率无显著差异。

核心结论

  • 高龄和较高的Charlson合并症指数分别与需要VVECMO患者的死亡风险增加相关。
  • 死亡率与BMI之间存在非线性关系,BMI 32至37之间者死亡 odds 低于BMI 25至32之间者。
  • 这种非线性模式提示需要进一步裁定与VVECMO相关的禁忌证,特别是仅基于BMI的禁忌证。

研究设计与样本

  • 回顾性队列分析,使用National COVID Cohort Collaborative数据,纳入美国31个医院系统2019年9月至2022年8月诊断严重急性呼吸综合征冠状病毒2感染且BMI≤60的患者1,033,229例。
  • 对住院期间需要VVECMO支持的患者进行单变量和多变量混合效应逻辑回归分析。
  • 进行亚组风险调整分析,比较BMI 40至60与BMI第25、50、75百分位患者的ECMO死亡率。

主要发现

  • 共774例成人需要VVECMO,其中542例为男性,中位年龄47岁,平均调整Charlson合并症指数为1,中位BMI为33。
  • 总体死亡率为47.8%。
  • 各医院间死亡率总体差异不显著(SD,0.31;95% CI,0-0.57)。
  • 多变量混合逻辑回归分析后,高龄(P<.0001)和Charlson合并症指数(P=.009)分别与死亡率增加相关;性别(P=.14)和机械通气时长(P=.39)与死亡率增加无关。
  • BMI从第25百分位增至第75百分位与死亡率差异无关(P=.28);多变量混合效应逻辑回归分析显示BMI与死亡率之间存在非线性关系,BMI 25至32之间患者死亡率增加,而BMI 32至37之间患者调整后死亡率随后下降。

关键数值与推荐

  • BMI 40至60与BMI第25、50、75百分位相比,ECMO死亡率无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Morbid obesity may influence candidacy for venovenous extracorporeal membrane oxygenation (VVECMO) support. Indeed, body mass index (BMI) >40 is considered to be a relative contraindication due to increased mortality observed in patients with BMI above this value. There is scant evidence to characterize this relationship beyond speculating about the technical challenges of cannulation and difficulty in optimizing flows. We examined a national cohort to evaluate the influence of BMI on mortality in patients requiring VVECMO for severe acute respiratory syndrome coronavirus 2 infection. METHODS: We performed a retrospective cohort analysis on National COVID Cohort Collaborative data evaluating 1,033,229 patients with BMI ≤60 from 31 US hospital systems diagnosed with severe acute respiratory syndrome virus coronavirus 2 infection from September 2019 to August 2022. We performed univariate and multivariable mixed-effects logistic regression analysis on data pertaining to those who required VVECMO support during their hospitalization. A subgroup risk-adjusted analysis comparing ECMO mortality in patients with BMI 40 to 60 with the 25th, 50th, and 75th BMI percentile was performed. Outcomes of interest included BMI, age, comorbidity score, body surface area, and ventilation days. RESULTS: A total of 774 adult patients required VVECMO. Of these, 542 were men, median age was 47 years, mean adjusted Charlson Comorbidity Index was 1, and median BMI was 33. Overall mortality was 47.8%. There was a nonsignificant overall difference in mortality across hospitals (SD, 0.31; 95% CI, 0-0.57). After mixed multivariable logistic regression analysis, advanced age (P < .0001) and Charlson Comorbidity Index (P = .009) were each associated with increased mortality. Neither gender (P = .14) nor duration on mechanical ventilation (P = .39) was associated with increased mortality. An increase in BMI from 25th to 75th percentile was not associated with a difference in mortality (P = .28). In our multivariable mixed-effects logistic regression analysis, there exists a nonlinear relationship between BMI and mortality. Between BMI of 25 and 32, patients experienced an increase in mortality. However, between BMI of 32 and 37, the adjusted mortality in these patients subsequently decreased. Our subgroup analysis comparing BMIs 40 to 60 with the 25th, 50th, and 75th percentile of BMI found no significant difference in ECMO mortality between BMI values of 40 and 60 with the 25th, 50th, 75th percentile. CONCLUSIONS: Advancing age and higher CCI are each associated with increased risk for mortality in patients requiring VVECMO. A nonlinear relationship exists between mortality and BMI and those between 32 and 37 have lower odds of mortality than those between BMI 25 and 32. This nonlinear pattern suggests a need for further adjudication of the contraindications associated with VVECMO, particularly those based solely on BMI.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Tham E, Campbell S, Hayanga H, et al. The relationship between body mass index and mortality is not linear in patients requiring venovenous extracorporeal support. J Thorac Cardiovasc Surg. 2023. PMID: 38042401. doi:10.1016/j.jtcvs.2023.11.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。